Weight‑loss drug ingredients may slow aging, says aging researcher Björn Schumacher
Executive summary: Björn Schumacher, an aging researcher at the University of Cologne, told Handelsblatt that genes influence roughly 30 % of lifespan, while the other 70 % is shaped by lifestyle and external factors, and he noted that the active ingredients in weight‑loss injections might slow the aging process. Linking obesity drugs to geroprotective effects highlights a crossover between metabolic health and longevity research that could spur new drug indications, attract investment in longevity biotech, and affect healthcare reimbursement and public‑health planning. Björn Schumacher (aging researcher, University of Cologne), Handelsblatt (interview platform), and implicitly the makers of GLP‑1‑based weight‑loss drugs such as Novo Nordisk and Eli Lilly. Further clinical trials testing GLP‑1 analogues for age‑related biomarkers, partnership talks between obesity drug makers and longevity firms, regulatory guidance on off‑label use for aging indications, and increased venture capital flow into longevity‑focused startups.
The interview with aging researcher Björn Schumacher highlights that genetics account for only about 30 % of human lifespan, leaving the remaining 70 % to lifestyle, environment and potential medical interventions. By noting that the active substances in weight‑loss injections could retard aging, the article points to a growing convergence between obesity treatment and longevity research, with possible implications for pharmaceutical pipelines, healthcare spending and the emerging anti‑aging market.
Connected developments
- Kapitalrente: Fünfzig Euro im Monat – und Deutschland hat wieder eine Perspektive
- Longevity: „Die Wirkstoffe der Abnehmspritzen könnten das Altern verlangsamen“
- Longevity: „Die Wirkstoffe der Abnehmspritzen könnten das Altern verlangsamen“
- Longevity: „Die Wirkstoffe der Abnehmspritzen könnten das Altern verlangsamen“
Open the full case file on Beyond →
Social Pulse
AI estimate · not scraped